NACDS Urges FDA, HHS to Preserve Medication Access as Supply Chain Pursues DSCSA Compliance
This situation jeopardizes patients' access to prescription drugs, through no fault of dispensers.
This situation jeopardizes patients' access to prescription drugs, through no fault of dispensers.
On September 17, NACDS and representatives from NACDS member pharmacies participated in a meeting with the White House Office of Pandemic Preparedness and Response Policy to discuss pharmacy needs for the current respiratory season as well as future, potential response efforts. Pictured here left to right on the front row are Sara Roszak, NACDS’ senior vice president of health and wellness strategy and policy; Anita Patel, vice president of pharmacy services development, Walgreen Co.; and Doug Cornelius, director of pharmacy operations, Kroger Health. Pictured in the back row left to right are Lisa Smith, senior director II, clinical operations and strategy, Walmart Health and Wellness; Summer Kerley, group vice president of pharmacy growth and operations, Rite Aid Corporation; past NACDS Chair Mike Wysong, chief executive officer of CARE Pharmacies; Charley John, senior director of healthcare policy and strategy, Walgreen Co.; NACDS President and CEO Steven C. Anderson; and Nimesh Jhaveri, executive vice president and chief impact officer, McKesson Corporation.
RELATED CONTENT
HHS Releases National Public Education Campaign for Respiratory Virus Season
The White House and HHS have reached out to NACDS to help share the national public education campaign with pharmacies, and in turn, NACDS is urging the federal government do their part as the nation enters the fall respiratory illness season.
NACDS’ Nourish Ny Health initiative, a newly released Milken Institute Action Plan, and a Leavitt Partners report on pharmacy data interoperability are among the latest.
Wyden letter urges Centers for Medicare & Medicaid Services to “conduct immediate oversight and rigorous regulatory enforcement of specific Medicare Part D program requirements for plan sponsors and their PBMs.”
NACDS also is urging Congress to enact in the 118th Congress PBM reforms in Medicare, Medicaid and the commercial markets: all levels and branches of government must do their jobs.
The New York Times publishes first article in a series: “The Middlemen: The Opaque Industry Secretly Inflating Prices for Prescription Drugs; Pharmacy benefit managers are driving up drug costs for millions of people, employers, and the government.”
The newly released Action Plan comes as part of NACDS’ joint commitment with the Milken Institute to the White House Challenge to End Hunger and Build Healthy Communities
Responds to RFI from Department of Justice, Department of Health and Human Services, and Federal Trade Commission.
Milken Institute's Holly Freishtat and NACDS' Steven C. Anderson - elaborated on a major announcement about food is medicine.
NACDS is reminding lawmakers that pharmacies and pharmacists have an important role to play when it comes to driving food is medicine initiatives, providing prevention and management services for chronic disease, and delivering total health and wellness solutions.